Assistant Professor of Pharmacology and Biomedical Engineering
Bio
Dr. Ji joined Northwestern University in 2018 and is a member of the Robert H. Lurie Comprehensive Cancer Center. He received his Ph.D. in computational genomics from Rutgers University in 2012 and completed his postdoctoral training in cancer systems biology and computational biology at Harvard Medical School and the Broad Institute of MIT and Harvard in 2017. Dr. Ji has received the NIH Pathway to Independence Award (K99/R00) and the Dean Morris Schaffer Endowed Scholarship from Rutgers University.
Dr. Ji’s group is studying the steps of breast cancer progression by dissecting the gene regulatory network and RNA translation, using unbiased, high-throughput genomic sequencing technologies and computational modeling. His group’s ultimate goal is to reveal novel therapeutic strategies for personalized cancer treatment.
Zhe Ji, PhD
Northwestern University Feinberg School of Medicine
Newly funded researchers pursuing high-risk, high-reward breast cancer studies in their first or second academic positions.
Past
Early Investigator
Abde Abukhdeir, PhD
The molecular variants that lead or contribute to drug resistance in breast cancer
Past
Early Investigator
Nan Chen, MD
Discovering novel biomarkers of therapy response and resistance in metastatic triple-negative breast cancer patients
Past
Early Investigator
Peiwen Chen, PhD
Targeting macrophage reprogramming in brain metastatic breast cancer
Why your gift matters
Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.
